RECRUITING

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Description

A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis

Conditions

Sickle Cell DiseaseSickle Cell AnemiaOsteonecrosisIschemic NecrosisAvascular Necrosis
Talk to us

Related Conditions:

Sickle Cell DiseaseSickle Cell AnemiaOsteonecrosisIschemic NecrosisAvascular Necrosis

Study Overview

On this page

Study Details

Study overview

A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis

A Feasibility Study of Alendronate as Treatment for Osteonecrosis in Adults With Sickle Cell Disease

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Condition
Sickle Cell Disease
Intervention / Treatment

-

Contacts and Locations

Sacramento

UC Davis Comprehensive Cancer Center, Sacramento, California, United States, 95817

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18-80 years with SCD (any genotype, confirmed by hemoglobin electrophoresis or high performance liquid chromatography)
  • * Ability to provide written informed consent
  • * Ability to lay on a dual-energy X-ray absorptiometry (DXA) scanner
  • * Negative urine pregnancy test for anyone of childbearing potential at study entry
  • * Pregnant women
  • * Adults unable to consent
  • * Individuals who are not yet adults (infants, children, teenagers)
  • * Prisoners
  • * Hospitalizations (for any cause) within 2 weeks of study entry

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, Davis,

Oyebimpe O Adesina, MD, MS, PRINCIPAL_INVESTIGATOR, UC Davis School of Medicine

Study Record Dates

2026-06